Biological Drugs: Challenges to Access
Amit Senguta
Biological Drugs: Challenges to Access - Malaysia: Third World Network, 2018. - 38p.
978-967-0747-26-2
The Growing Therapeutic and Commercial Importance
How Biological Drugs Differ from Small Molecule Drugs
Recombinant Technologies in the Manufacture of Biological Drugs
Renewed Interest in Biological Medicines
Why are Biologics and Biosimilars So Expensive
Biosimilas vs Generics of SMDs
Technological Barriers to Manufacture of Biosimilars
Barriers Related to Intellectual Property Rights and Data Exclusivity
The Evolving Regulatory Landscape for Approval of Biosimilars
How necessary are Present Requirements to Establish Similarity
615.32 / AMI
Biological Drugs: Challenges to Access - Malaysia: Third World Network, 2018. - 38p.
978-967-0747-26-2
The Growing Therapeutic and Commercial Importance
How Biological Drugs Differ from Small Molecule Drugs
Recombinant Technologies in the Manufacture of Biological Drugs
Renewed Interest in Biological Medicines
Why are Biologics and Biosimilars So Expensive
Biosimilas vs Generics of SMDs
Technological Barriers to Manufacture of Biosimilars
Barriers Related to Intellectual Property Rights and Data Exclusivity
The Evolving Regulatory Landscape for Approval of Biosimilars
How necessary are Present Requirements to Establish Similarity
615.32 / AMI